September

Blog Posts in September, 2017

  • First Equifax "Data Breach" Class Action Lawsuit

    The law firms of Bingham Greenebaum Doll, PLLC and Brett H. Oppenheimer, PLLC on Friday filed the first Equifax “data breach” class action lawsuit in the Federal Court/Western District of Kentucky. The lawsuit was filed on behalf of Robert Todd Benson and others similarly situated. Mr. Benson went to www.equifaxsecurity2017.com and learned that he was a possible victim of the breach. ...
    Continue Reading

  • Rheumatoid Arthritis Drug Actemra Linked to 100+ User Deaths

    The rheumatoid arthritis (RA) medication Actemra – which is a brand-prescription for the medication called tocilizumab – has been linked by recent studies to serious and potentially fatal side effects when taken by users of all age groups. The publication group STAT conducted the study by pouring over more than half a million reports regarding RA drug side effects and ultimately concluded that ...
    Continue Reading

  • FDA Issues Critical Letter to EpiPen for Failure to Address Product Failures

    In early September 2017, the U.S. Food and Drug Administration (FDA) sent a scathing letter to Meridian Medical Technologies rebuking the company for failing to investigate and address component and product failures in its EpiPen products. The FDA cited hundreds of customer complaints that were linked to life-threatening emergencies in which the EpiPen auto-injectors failed to operate correctly. ...
    Continue Reading

  • EQUIFAX DATA BREACH

    The news of the Equifax data breach is dominating headlines as it appears approximately 143 million American consumers are at risk of identity theft. There are already over 60 class action lawsuits filed in 26 states. Additionally, some state attorney generals have announced lawsuits claiming Equifax has violated state laws by not protecting people’s personal data. Equifax, based in Atlanta, GA, ...
    Continue Reading
Page 1 of 1